Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
04/2003
04/24/2003CA2463927A1 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof
04/24/2003CA2463911A1 Tumor targeted photodiagnostic-phototherapeutic agents
04/24/2003CA2463906A1 Pathological tissue detection and treatment employing targeted benzoindole optical agents
04/24/2003CA2463898A1 Methods and materials for targeting and affecting selected cells
04/24/2003CA2463816A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
04/24/2003CA2463771A1 Oligoamine compounds and derivatives thereof for cancer therapy
04/24/2003CA2463724A1 Organosulfur inhibitors of tyrosine phosphatases
04/24/2003CA2463686A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them
04/24/2003CA2463685A1 Novel .beta.-phenyl-.alpha.-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds
04/24/2003CA2463672A1 Direct targeting binding proteins
04/24/2003CA2463628A1 Himbacine analogues as thrombin receptor antagonists
04/24/2003CA2463571A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
04/24/2003CA2463518A1 Carbinols for the treatment of neuropathic dysfunction
04/24/2003CA2463492A1 Methods for the treatment of carcinoma
04/24/2003CA2463426A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof
04/24/2003CA2463159A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors
04/24/2003CA2463136A1 Ship 1 modulators
04/24/2003CA2462785A1 Kinases and phosphatases
04/24/2003CA2462642A1 Use of aplidine for the treatment of pancreatic cancer
04/24/2003CA2462639A1 Kahalalide compounds for use in cancer therapy
04/24/2003CA2462442A1 Alkyne matrix metalloproteinase inhibitors
04/24/2003CA2462219A1 Pharmaceutical formulation comprising (r) -bicalutamide
04/24/2003CA2462147A1 Bicyclic oxopyridine and oxopyrimidine derivatives
04/24/2003CA2461575A1 Use of peptide vectors to improve the immune response to antigens
04/24/2003CA2461556A1 Compositions and methods for delivery of microparticles of poorly water soluble drugs and methods of treatment
04/24/2003CA2461542A1 Gap junctions and endothelial-derived hyperpolarizing factor (edhf)
04/24/2003CA2461245A1 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
04/24/2003CA2454578A1 Modified human thymic stromal lymphopoietin
04/23/2003EP1304379A2 Humanised antibody against CD18
04/23/2003EP1304371A1 Cds1 GENE-KNOCKOUT CELLS AND MOUSE AND UTILIZATION THEREOF
04/23/2003EP1304334A1 Novel antiandrogenic agent
04/23/2003EP1304123A2 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
04/23/2003EP1304111A2 Use of methylol-containing compounds for the treatment of breast cancer
04/23/2003EP1304110A2 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
04/23/2003EP1304101A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications
04/23/2003EP1304047A1 Extracts of cacao bean and cacao bean husk with inhibitory effects on carcinogenesis
04/23/2003EP1304046A1 Theobromine with an anti-carcinogenic activity
04/23/2003EP1303641A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
04/23/2003EP1303632A2 Galactomannan oligosaccharides and methods for the production and use thereof
04/23/2003EP1303620A2 Regulation of human desc1-like serine protease
04/23/2003EP1303619A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction
04/23/2003EP1303608A2 Zinc finger domain recognition code and uses thereof
04/23/2003EP1303600A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
04/23/2003EP1303599A2 Methylated nucleotide regulation of upa gene expression
04/23/2003EP1303594A2 Glycosylated vegf-b and method for increasing the amount of soluble vegf-b
04/23/2003EP1303592A1 Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same
04/23/2003EP1303540A2 Multi-specific reagent for selective stimulation of cell surface receptors
04/23/2003EP1303538A2 Ghrelin antagonists
04/23/2003EP1303533A2 Chimeric peptide immunogens, their preparation and use
04/23/2003EP1303527A1 Matrix metalloproteinase inhibitors
04/23/2003EP1303522A2 Biologically active macrolides, compositions, and uses thereof
04/23/2003EP1303520A1 Therapeutic compounds and methods
04/23/2003EP1303517A1 Indoloquinazolinones
04/23/2003EP1303513A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
04/23/2003EP1303512A1 Process for preparing arylacetylaminothiazoles
04/23/2003EP1303507A1 Pyrimidine derivatives
04/23/2003EP1303503A2 Aniline derivatives
04/23/2003EP1303496A1 Pyrimidine derivatives
04/23/2003EP1303492A2 Aza-bridged-bicyclic amino acid derivatives as alpha 4 integrin antagonists
04/23/2003EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors
04/23/2003EP1303485A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
04/23/2003EP1303482A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
04/23/2003EP1303481A1 Phenylethylamine derivatives and their use in the treatment of melanoma
04/23/2003EP1303479A2 7-, 8- and 9-substituted tetracycline compounds
04/23/2003EP1303310A1 USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS
04/23/2003EP1303307A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
04/23/2003EP1303299A1 Compositions and methods for enhancing immunogenicity of antigens
04/23/2003EP1303293A2 Apo-2l receptor agonist and cpt-11 synergism
04/23/2003EP1303291A1 Anti-hiv and anti-tumor peptides and fragments of lysozyme
04/23/2003EP1303286A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
04/23/2003EP1303284A1 Compositions and methods for the treatment of skin damage
04/23/2003EP1303282A1 Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides
04/23/2003EP1303281A1 Methods of treatment
04/23/2003EP1303271A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug
04/23/2003EP1303267A1 Dermal for amino laevulinic acid
04/23/2003EP1303261A2 Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs
04/23/2003EP1303259A1 Prolonged release microspheres for injection delivery and preparation method
04/23/2003EP1257537A4 Therapeutic morpholino-substituted compounds
04/23/2003EP1254131A4 Extraction of flavonoids
04/23/2003EP1250055A4 Immune modulation with death receptor-induced apoptosis
04/23/2003EP1242445B1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds
04/23/2003EP1185175B1 Method of increasing the content of flavonoids and phenolic substances in plants
04/23/2003EP1131063B1 Hyperforin ointment or cream
04/23/2003EP1121102B1 Liposome-entrapped topoisomerase inhibitors
04/23/2003EP1057033B1 Treating cancer
04/23/2003EP1057032B1 Treating cancer
04/23/2003EP1057031B1 Treating cancer
04/23/2003EP1057030B1 Treating cancer
04/23/2003EP1057029B1 Treating cancer
04/23/2003EP1057028B1 Treating cancer
04/23/2003EP1051387B1 Anticancer platinum (iv) complexes for oral administration
04/23/2003EP1035848B1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels
04/23/2003EP1027359B1 Monocyclic l-nucleosides, analogs and uses thereof
04/23/2003EP0873315B1 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives
04/23/2003EP0788373B1 Novel complexes of taxol or taxotere and pharmaceutical compositions
04/23/2003EP0764021B1 Uterine fibroid treatment
04/23/2003EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor
04/23/2003EP0546124B2 Multidomain hematopoiesis stimulators
04/23/2003CN1413258A Invasive bacterial vectors for expressing alphavirus replicons
04/23/2003CN1413250A Method of producing differentiated progenitor cells and lineage-defective embryonic stem cells
1 ... 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 ... 2211